- Lobbying
- Lobbying by Viatris, Inc.
Lobbying Relationship
Bills mentioned
H.R.4356: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Sanford D. Bishop Jr. (D-Ga.)
H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021
Sponsor: David McKinley (R-W.Va.)
H.R.4350: National Defense Authorization Act for Fiscal Year 2022
Sponsor: Adam Smith (D-Wash.)
H.R.4355: Military Construction, Veterans Affairs, and Related Agencies...
Sponsor: Debbie Wasserman Schultz (D-Fla.)
S.1773: Prescription Drug Pricing Dashboard Act
Sponsor: Bob Casey (D-Pa.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
H.R.6973: Enhanced Access to Affordable Medicines Act of 2022
Sponsor: Buddy Carter (R-Ga.)
H.R.7032: Increasing Transparency in Generic Drug Applications Act of 2022
Sponsor: Ann McLane Kuster (D-N.H.)
S.775: Increasing Transparency in Generic Drug Applications Act
Sponsor: Margaret Hassan (D-N.H.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Thomas M. Davis | Member, U.S. House of Representatives |
Miranda Franco | n/a |
Michael Werner | n/a |
Ethan Jorgensen-Earp | n/a |
Thomas M Davis | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate